Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).

× No keyword cloud information.

18 in total

Review 1. Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.

Authors: M Asif A Siddiqui; Lesley J Scott
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 2. Key issues in inhibitor management in patients with haemophilia.

Authors: Keith Gomez; Robert Klamroth; Johnny Mahlangu; Maria E Mancuso; María E Mingot; Margareth Castro Ozelo
Journal: Blood Transfus Date: 2013-12-03 Impact factor: 3.443

Review 3. Immune tolerance induction for patients with severe hemophilia A: a critical literature review.

Authors: Massimo Franchini; Giuseppe Lippi
Journal: J Thromb Thrombolysis Date: 2011-11 Impact factor: 2.300

4. Acquired factor VIII deficiency after consuming the dried gallbladder of a cobra, Naja naja.

Authors: Hyun Ju Kim; Won Sik Lee; Young Jin Lee; Hyun Soo Jun; Su-Kil Seo; Young-Don Joo
Journal: Korean J Hematol Date: 2010-09-30

5. Clinical Characteristics and Prognostic Factors in Hemophiliacs with Intracranial Hemorrhage: A Single-Center, Retrospective Experience.

Authors: Jung Yoon Cho; Won Seok Lee; Young Shil Park; Seung Hwan Lee; Jun Seok Koh
Journal: Indian J Hematol Blood Transfus Date: 2016-01-12 Impact factor: 0.900

Review 10. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.

Authors: Davide Matino; Michael Makris; Kerry Dwan; Roberto D'Amico; Alfonso Iorio
Journal: Cochrane Database Syst Rev Date: 2015-12-16

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).

Review 1. Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.

Review 2. Key issues in inhibitor management in patients with haemophilia.

Review 3. Immune tolerance induction for patients with severe hemophilia A: a critical literature review.

4. Acquired factor VIII deficiency after consuming the dried gallbladder of a cobra, Naja naja.

5. Clinical Characteristics and Prognostic Factors in Hemophiliacs with Intracranial Hemorrhage: A Single-Center, Retrospective Experience.

Review 6. State of care for hemophilia in pediatric patients.

Review 7. Treatment of patients with haemophilia and inhibitory antibodies.

8. Acquired haemophilia A as a blood transfusion emergency.

Review 9. Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives.

Review 10. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.